22 U.S.C. § 7611 — Development of a comprehensive, five-

Page 1971 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 7611 partnerships to combat HIV/AIDS, tuber- culosis, and malaria; (5) reinforcing efforts to— (A) develop safe and effective vaccines, microbicides, and other prevention and treatment technologies; and (B) improve diagnostics capabilities for HIV/AIDS, tuberculosis, and malaria; and (6) helping partner countries to— (A) strengthen health systems; (B) expand health workforce; and (C) address infrastructural weaknesses. (Pub. L. 108–25, § 4, May 27, 2003, 117 Stat. 717; Pub. L. 110–293, § 4, July 30, 2008, 122 Stat. 2922.) Editorial Notes REFERENCES IN TEXT This chapter, referred to in text, was in the original ‘‘this Act’’, meaning Pub. L. 108–25, May 27, 2003, 117 Stat. 711, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 7601 of this title and Tables. AMENDMENTS 2008—Pub. L. 110–293 amended section generally. Prior to amendment, section stated the purpose of this chap- ter. § 7604. Authority to consolidate and combine re- ports With respect to the reports required by this chapter to be submitted by the President, to en- sure an efficient use of resources, the President may, in his discretion and notwithstanding any other provision of this chapter, consolidate or combine any of these reports, except for the re- port required by section 7611 of this title, so long as the required elements of each report are ad- dressed and reported within a 90-day period from the original deadline date for submission of the report specified in this chapter. The President may also enter into contracts with organiza- tions with relevant expertise to develop, origi- nate, or contribute to any of the reports re- quired by this chapter to be submitted by the President, with the exception of the 5-year strategy. (Pub. L. 108–25, § 5, May 27, 2003, 117 Stat. 718; Pub. L. 110–293, § 5, July 30, 2008, 122 Stat. 2922.) Editorial Notes REFERENCES IN TEXT This chapter, referred to in text, was in the original ‘‘this Act’’, meaning Pub. L. 108–25, May 27, 2003, 117 Stat. 711, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 7601 of this title and Tables. AMENDMENTS 2008—Pub. L. 110–293 inserted ‘‘, with the exception of the 5-year strategy’’ before the period at end. Executive Documents DELEGATION OF FUNCTIONS For delegation of functions of President under this section, see Ex. Ord. No. 12163, Sept. 29, 1979, 44 F.R. 56673, as amended, set out as a note under section 2381 of this title. SUBCHAPTER I—POLICY PLANNING AND COORDINATION § 7611. Development of a comprehensive, five- year, global strategy (a) Strategy The President shall establish a comprehensive, integrated, 5-year strategy to expand and im- prove efforts to combat global HIV/AIDS. This strategy shall— (1) further strengthen the capability of the United States to be an effective leader of the international campaign against this disease and strengthen the capacities of nations expe- riencing HIV/AIDS epidemics to combat this disease; (2) maintain sufficient flexibility and remain responsive to— (A) changes in the epidemic; (B) challenges facing partner countries in developing and implementing an effective national response; and (C) evidence-based improvements and inno- vations in the prevention, care, and treat- ment of HIV/AIDS; (3) situate United States efforts to combat HIV/AIDS, tuberculosis, and malaria within the broader United States global health and development agenda, establishing a roadmap to link investments in specific disease pro- grams to the broader goals of strengthening health systems and infrastructure and to inte- grate and coordinate HIV/AIDS, tuberculosis, or malaria programs with other health or de- velopment programs, as appropriate; (4) provide a plan to— (A) prevent 12,000,000 new HIV infections worldwide; (B) support— (i) the increase in the number of individ- uals with HIV/AIDS receiving antiretroviral treatment above the goal established under section 7672(a)(3) of this title and increased pursuant to paragraphs (1) through (3) of section 7673(d) of this title; and (ii) additional treatment through coordi- nated multilateral efforts; (C) support care for 12,000,000 individuals infected with or affected by HIV/AIDS, in- cluding 5,000,000 orphans and vulnerable chil- dren affected by HIV/AIDS, with an empha- sis on promoting a comprehensive, coordi- nated system of services to be integrated throughout the continuum of care; (D) help partner countries in the effort to achieve goals of 80 percent access to coun- seling, testing, and treatment to prevent the transmission of HIV from mother to child, emphasizing a continuum of care model; (E) help partner countries to provide care and treatment services to children with HIV in proportion to their percentage within the HIV-infected population in each country; (F) promote preservice training for health professionals designed to strengthen the ca- pacity of institutions to develop and imple- Page 1972 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 7611 ment policies for training health workers to combat HIV/AIDS, tuberculosis, and ma- laria; (G) equip teachers with skills needed for HIV/AIDS prevention and support for per- sons with, or affected by, HIV/AIDS; (H) provide and share best practices for combating HIV/AIDS with health profes- sionals; (I) promote pediatric HIV/AIDS training for physicians, nurses, and other health care workers, through public-private partner- ships if possible, including through the des- ignation, if appropriate, of centers of excel- lence for training in pediatric HIV/AIDS pre- vention, care, and treatment in partner countries; and (J) help partner countries to train and sup- port retention of health care professionals and paraprofessionals, with the target of training and retaining at least 140,000 new health care professionals and paraprofes- sionals with an emphasis on training and in country deployment of critically needed doc- tors and nurses and to strengthen capacities in developing countries, especially in sub- Saharan Africa, to deliver primary health care with the objective of helping countries achieve staffing levels of at least 2.3 doctors, nurses, and midwives per 1,000 population, as called for by the World Health Organization; (5) include multisectoral approaches and spe- cific strategies to treat individuals infected with HIV/AIDS and to prevent the further transmission of HIV infections, with a par- ticular focus on the needs of families with children (including the prevention of mother- to-child transmission), women, young people, orphans, and vulnerable children; (6) establish a timetable with annual global treatment targets with country-level bench- marks for antiretroviral treatment; (7) expand the integration of timely and rel- evant research within the prevention, care, and treatment of HIV/AIDS; (8) include a plan for program monitoring, operations research, and impact evaluation and for the dissemination of a best practices report to highlight findings; (9) support the in-country or intra-regional training, preferably through public-private partnerships, of scientific investigators, man- agers, and other staff who are capable of pro- moting the systematic uptake of clinical re- search findings and other evidence-based interventions into routine practice, with the goal of improving the quality, effectiveness, and local leadership of HIV/AIDS health care; (10) expand and accelerate research on and development of HIV/AIDS prevention methods for women, including enhancing inter-agency collaboration, staffing, and organizational in- frastructure dedicated to microbicide re- search; (11) provide for consultation with local lead- ers and officials to develop prevention strate- gies and programs that are tailored to the unique needs of each country and community and targeted particularly toward those most at risk of acquiring HIV infection; (12) make the reduction of HIV/AIDS behav- ioral risks a priority of all prevention efforts by— (A) promoting abstinence from sexual ac- tivity and encouraging monogamy and faith- fulness; (B) encouraging the correct and consistent use of male and female condoms and increas- ing the availability of, and access to, these commodities; (C) promoting the delay of sexual debut and the reduction of multiple concurrent sexual partners; (D) promoting education for discordant couples (where an individual is infected with HIV and the other individual is uninfected or whose status is unknown) about safer sex practices; (E) promoting voluntary counseling and testing, addiction therapy, and other preven- tion and treatment tools for illicit injection drug users and other substance abusers; (F) educating men and boys about the risks of procuring sex commercially and about the need to end violent behavior to- ward women and girls; (G) supporting partner country and com- munity efforts to identify and address so- cial, economic, or cultural factors, such as migration, urbanization, conflict, gender- based violence, lack of empowerment for women, and transportation patterns, which directly contribute to the transmission of HIV; (H) supporting comprehensive programs to promote alternative livelihoods, safety, and social reintegration strategies for commer- cial sex workers and their families; (I) promoting cooperation with law en- forcement to prosecute offenders of traf- ficking, rape, and sexual assault crimes with the goal of eliminating such crimes; and (J) working to eliminate rape, gender- based violence, sexual assault, and the sex- ual exploitation of women and children; (13) include programs to reduce the trans- mission of HIV, particularly addressing the heightened vulnerabilities of women and girls to HIV in many countries; and (14) support other important means of pre- venting or reducing the transmission of HIV, including— (A) medical male circumcision; (B) the maintenance of a safe blood supply; (C) promoting universal precautions in for- mal and informal health care settings; (D) educating the public to recognize and to avoid risks to contract HIV through blood exposures during formal and informal health care and cosmetic services; (E) investigating suspected nosocomial in- fections to identify and stop further nosocomial transmission; and (F) other mechanisms to reduce the trans- mission of HIV; (15) increase support for prevention of moth- er-to-child transmission; (16) build capacity within the public health sector of developing countries by improving health systems and public health infrastruc- Page 1973 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 7611 ture and developing indicators to measure changes in broader public health sector capa- bilities; (17) increase the coordination of HIV/AIDS programs with development programs; (18) provide a framework for expanding or developing existing or new country or regional programs, including— (A) drafting compacts or other agree- ments, as appropriate; (B) establishing criteria and objectives for such compacts and agreements; and (C) promoting sustainability; (19) provide a plan for national and regional priorities for resource distribution and a glob- al investment plan by region; (20) provide a plan to address the immediate and ongoing needs of women and girls, which— (A) addresses the vulnerabilities that con- tribute to their elevated risk of infection; (B) includes specific goals and targets to address these factors; (C) provides clear guidance to field mis- sions to integrate gender across prevention, care, and treatment programs; (D) sets forth gender-specific indicators to monitor progress on outcomes and impacts of gender programs; (E) supports efforts in countries in which women or orphans lack inheritance rights and other fundamental protections to pro- mote the passage, implementation, and en- forcement of such laws; (F) supports life skills training, especially among women and girls, with the goal of re- ducing vulnerabilities to HIV/AIDS; (G) addresses and prevents gender-based violence; and (H) addresses the posttraumatic and psy- chosocial consequences and provides postexposure prophylaxis protecting against HIV infection to victims of gender-based vio- lence and rape; (21) provide a plan to— (A) determine the local factors that may put men and boys at elevated risk of con- tracting or transmitting HIV; (B) address male norms and behaviors to reduce these risks, including by reducing al- cohol abuse; (C) promote responsible male behavior; and (D) promote male participation and leader- ship at the community level in efforts to promote HIV prevention, reduce stigma, pro- mote participation in voluntary counseling and testing, and provide care, treatment, and support for persons with HIV/AIDS; (22) provide a plan to address the vulnerabilities and needs of orphans and chil- dren who are vulnerable to, or affected by, HIV/AIDS; (23) encourage partner countries to develop health care curricula and promote access to training tailored to individuals receiving serv- ices through, or exiting from, existing pro- grams geared to orphans and vulnerable chil- dren; (24) provide a framework to work with inter- national actors and partner countries toward universal access to HIV/AIDS prevention, treatment, and care programs, recognizing that prevention is of particular importance; (25) enhance the coordination of United States bilateral efforts to combat global HIV/ AIDS with other major public and private en- tities; (26) enhance the attention given to the na- tional strategic HIV/AIDS plans of countries receiving United States assistance by— (A) reviewing the planning and pro- grammatic decisions associated with that assistance; and (B) helping to strengthen such national strategies, if necessary; (27) support activities described in the Glob- al Plan to Stop TB, including— (A) expanding and enhancing the coverage of the Directly Observed Treatment Short- course (DOTS) in order to treat individuals infected with tuberculosis and HIV, includ- ing multi-drug resistant or extensively drug resistant tuberculosis; and (B) improving coordination and integra- tion of HIV/AIDS and tuberculosis program- ming; (28) ensure coordination between the Global AIDS Coordinator and the Malaria Coordi- nator and address issues of comorbidity be- tween HIV/AIDS and malaria; and (29) include a longer term estimate of the projected resource needs, progress toward greater sustainability and country ownership of HIV/AIDS programs, and the anticipated role of the United States in the global effort to combat HIV/AIDS during the 10-year period beginning on October 1, 2013. (b) Report (1) In general Not later than October 1, 2009, the President shall submit a report to the appropriate con- gressional committees that sets forth the strategy described in subsection (a). (2) Contents The report required under paragraph (1) shall include a discussion of the following ele- ments: (A) The purpose, scope, methodology, and general and specific objectives of the strat- egy. (B) The problems, risks, and threats to the successful pursuit of the strategy. (C) The desired goals, objectives, activi- ties, and outcome-related performance meas- ures of the strategy. (D) A description of future costs and re- sources needed to carry out the strategy. (E) A delineation of United States Govern- ment roles, responsibility, and coordination mechanisms of the strategy. (F) A description of the strategy— (i) to promote harmonization of United States assistance with that of other inter- national, national, and private actors as elucidated in the ‘‘Three Ones’’; and (ii) to address existing challenges in har- monization and alignment. (G) A description of the manner in which the strategy will— Page 1974 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 7611 (i) further the development and imple- mentation of the national multisectoral strategic HIV/AIDS frameworks of partner governments; and (ii) enhance the centrality, effectiveness, and sustainability of those national plans. (H) A description of how the strategy will seek to achieve the specific targets described in subsection (a) and other targets, as appro- priate. (I) A description of, and rationale for, the timetable for annual global treatment tar- gets with country-level estimates of num- bers of persons in need of antiretroviral treatment, country-level benchmarks for United States support for assistance for antiretroviral treatment, and numbers of persons enrolled in antiretroviral treatment programs receiving United States support. If global benchmarks are not achieved within the reporting period, the report shall include a description of steps being taken to ensure that global benchmarks will be achieved and a detailed breakdown and justification of spending priorities in countries in which benchmarks are not being met, including a description of other donor or national sup- port for antiretroviral treatment in the country, if appropriate. (J) A description of how operations re- search is addressed in the strategy and how such research can most effectively be inte- grated into care, treatment, and prevention activities in order to— (i) improve program quality and effi- ciency; (ii) ascertain cost effectiveness; (iii) ensure transparency and account- ability; (iv) assess population-based impact; (v) disseminate findings and best prac- tices; and (vi) optimize delivery of services. (K) An analysis of United States-assisted strategies to prevent the transmission of HIV/AIDS, including methodologies to pro- mote abstinence, monogamy, faithfulness, the correct and consistent use of male and female condoms, reductions in concurrent sexual partners, and delay of sexual debut, and of intended monitoring and evaluation approaches to measure the effectiveness of prevention programs and ensure that they are targeted to appropriate audiences. (L) Within the analysis required under subparagraph (K), an examination of addi- tional planned means of preventing the transmission of HIV including medical male circumcision, maintenance of a safe blood supply, public education about risks to ac- quire HIV infection from blood exposures, promotion of universal precautions, inves- tigation of suspected nosocomial infections and other tools. (M) A description of efforts to assist part- ner country and community to identify and address social, economic, or cultural factors, such as migration, urbanization, conflict, gender-based violence, lack of empowerment for women, and transportation patterns, which directly contribute to the trans- mission of HIV. (N) A description of the specific targets, goals, and strategies developed to address the needs and vulnerabilities of women and girls to HIV/AIDS, including— (i) activities directed toward men and boys; (ii) activities to enhance educational, microfinance, and livelihood opportunities for women and girls; (iii) activities to promote and protect the legal empowerment of women, girls, and orphans and vulnerable children; (iv) programs targeted toward gender- based violence and sexual coercion; (v) strategies to meet the particular needs of adolescents; (vi) assistance for victims of rape, sexual abuse, assault, exploitation, and traf- ficking; and (vii) programs to prevent alcohol abuse. (O) A description of strategies to address male norms and behaviors that contribute to the transmission of HIV, to promote respon- sible male behavior, and to promote male participation and leadership in HIV/AIDS prevention, care, treatment, and voluntary counseling and testing. (P) A description of strategies— (i) to address the needs of orphans and vulnerable children, including an analysis of— (I) factors contributing to children’s vulnerability to HIV/AIDS; and (II) vulnerabilities caused by the im- pact of HIV/AIDS on children and their families; and (ii) in areas of higher HIV/AIDS preva- lence, to promote a community-based ap- proach to vulnerability, maximizing com- munity input into determining which chil- dren participate. (Q) A description of capacity-building ef- forts undertaken by countries themselves, including adherents of the Abuja Declara- tion and an assessment of the impact of International Monetary Fund macro- economic and fiscal policies on national and donor investments in health. (R) A description of the strategy to— (i) strengthen capacity building within the public health sector; (ii) improve health care in those coun- tries; (iii) help countries to develop and imple- ment national health workforce strategies; (iv) strive to achieve goals in training, retaining, and effectively deploying health staff; (v) promote the use of codes of conduct for ethical recruiting practices for health care workers; and (vi) increase the sustainability of health programs. (S) A description of the criteria for selec- tion, objectives, methodology, and structure of compacts or other framework agreements with countries or regional organizations, in- cluding— Page 1975 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 7611 (i) the role of civil society; (ii) the degree of transparency; (iii) benchmarks for success of such com- pacts or agreements; and (iv) the relationship between such com- pacts or agreements and the national HIV/ AIDS and public health strategies and commitments of partner countries. (T) A strategy to better coordinate HIV/ AIDS assistance with nutrition and food as- sistance programs. (U) A description of transnational or re- gional initiatives to combat regionalized epidemics in highly affected areas such as the Caribbean. (V) A description of planned resource dis- tribution and global investment by region. (W) A description of coordination efforts in order to better implement the Stop TB Strategy and to address the problem of co- infection of HIV/AIDS and tuberculosis and of projected challenges or barriers to suc- cessful implementation. (X) A description of coordination efforts to address malaria and comorbidity with ma- laria and HIV/AIDS. (c) Study of progress toward achievement of pol- icy objectives (1) Design and budget plan for data evaluation The Global AIDS Coordinator shall enter into a contract with the Institute of Medicine of the National Academies that provides that not later than 18 months after July 30, 2008, the Institute, in consultation with the Global AIDS Coordinator and other relevant parties representing the public and private sector, shall provide the Global AIDS Coordinator with a design plan and budget for the evalua- tion and collection of baseline and subsequent data to address the elements set forth in para- graph (2)(B). The Global AIDS Coordinator shall submit the budget and design plan to the appropriate congressional committees. (2) Study (A) In general Not later than 4 years after July 30, 2008, the Institute of Medicine of the National Academies shall publish a study that in- cludes— (i) an assessment of the performance of United States-assisted global HIV/AIDS programs; and (ii) an evaluation of the impact on health of prevention, treatment, and care efforts that are supported by United States funding, including multilateral and bilat- eral programs involving joint operations. (B) Content The study conducted under this paragraph shall include— (i) an assessment of progress toward pre- vention, treatment, and care targets; (ii) an assessment of the effects on health systems, including on the financing and management of health systems and the quality of service delivery and staff- ing; (iii) an assessment of efforts to address gender-specific aspects of HIV/AIDS, in- cluding gender related constraints to ac- cessing services and addressing underlying social and economic vulnerabilities of women and men; (iv) an evaluation of the impact of treat- ment and care programs on 5-year survival rates, drug adherence, and the emergence of drug resistance; (v) an evaluation of the impact of pre- vention programs on HIV incidence in rel- evant population groups; (vi) an evaluation of the impact on child health and welfare of interventions au- thorized under this chapter on behalf of or- phans and vulnerable children; (vii) an evaluation of the impact of pro- grams and activities authorized in this chapter on child mortality; and (viii) recommendations for improving the programs referred to in subparagraph (A)(i). (C) Methodologies Assessments and impact evaluations con- ducted under the study shall utilize sound statistical methods and techniques for the behavioral sciences, including random as- signment methodologies as feasible. Quali- tative data on process variables should be used for assessments and impact evalua- tions, wherever possible. (3) Contract authority The Institute of Medicine may enter into contracts or cooperative agreements or award grants to conduct the study under paragraph (2). (4) Authorization of appropriations There are authorized to be appropriated such sums as may be necessary to carry out the study under this subsection. (d) Comptroller General report (1) Report required Not later than 3 years after July 30, 2008, the Comptroller General of the United States shall submit a report on the global HIV/AIDS pro- grams of the United States to the appropriate congressional committees. (2) Contents The report required under paragraph (1) shall include— (A) a description and assessment of the monitoring and evaluation practices and policies in place for these programs; (B) an assessment of coordination within Federal agencies involved in these programs, examining both internal coordination within these programs and integration with the larger global health and development agenda of the United States; (C) an assessment of procurement policies and practices within these programs; (D) an assessment of harmonization with national government HIV/AIDS and public health strategies as well as other inter- national efforts; (E) an assessment of the impact of global HIV/AIDS funding and programs on other United States global health programming; and Page 1976 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 7611 (F) recommendations for improving the global HIV/AIDS programs of the United States. (e) Best practices report (1) In general Not later than 1 year after July 30, 2008, and annually thereafter, the Global AIDS Coordi- nator shall publish a best practices report that highlights the programs receiving financial as- sistance from the United States that have the potential for replication or adaption, particu- larly at a low cost, across global AIDS pro- grams, including those that focus on both gen- eralized and localized epidemics. (2) Dissemination of findings (A) Publication on Internet website The Global AIDS Coordinator shall dis- seminate the full findings of the annual best practices report on the Internet website of the Office of the Global AIDS Coordinator. (B) Dissemination guidance The Global AIDS Coordinator shall de- velop guidance to ensure timely submission and dissemination of significant information regarding best practices with respect to global AIDS programs. (f) Inspectors General (1) Oversight plan (A) Development The Inspectors General of the Department of State and Broadcasting Board of Gov- ernors, the Department of Health and Human Services, and the United States Agency for International Development shall jointly develop coordinated annual plans for oversight activity in each of the fiscal years 2009 through March 25 of fiscal year 2025, with regard to the programs authorized under this chapter and sections 2151b–2, 2151b–3, and 2151b–4 of this title. (B) Contents The plans developed under subparagraph (A) shall include a schedule for financial au- dits, inspections, and performance reviews, as appropriate. (C) Deadline (i) Initial plan The first plan developed under subpara- graph (A) shall be completed not later than the later of— (I) September 1, 2008; or (II) 60 days after July 30, 2008. (ii) 2010 through 2013 plans Each of the plans for fiscal years 2010 through 2013 developed under subparagraph (A) shall be completed not later than 30 days before each of the fiscal years 2010 through 2013, respectively. (iii) 2014 plan The plan developed under subparagraph (A) for fiscal year 2014 shall be completed not later than 60 days after December 2, 2013. (iv) Subsequent plans Each of the last eleven plans developed under subparagraph (A) shall be completed not later than 30 days before each of the fiscal years 2015 through 2025, respectively. (2) Coordination In order to avoid duplication and maximize efficiency, the Inspectors General described in paragraph (1) shall coordinate their activities with— (A) the Government Accountability Office; and (B) the Inspectors General of the Depart- ment of Commerce, the Department of De- fense, the Department of Labor, and the Peace Corps, as appropriate, pursuant to the 2004 Memorandum of Agreement Coordi- nating Audit Coverage of Programs and Ac- tivities Implementing the President’s Emer- gency Plan for AIDS Relief, or any successor agreement. (3) Funding The Global AIDS Coordinator and the Coor- dinator of the United States Government Ac- tivities to Combat Malaria Globally shall make available necessary funds not exceeding $15,000,000 during the 5-year period beginning on October 1, 2008 to the Inspectors General described in paragraph (1) for the audits, in- spections, and reviews described in that para- graph. (g) Annual study (1) In general Not later than September 30, 2009, and annu- ally thereafter through March 25, 2025, the Global AIDS Coordinator shall complete a study of treatment providers that— (A) represents a range of countries and service environments; (B) estimates the per-patient cost of antiretroviral HIV/AIDS treatment and the care of people with HIV/AIDS not receiving antiretroviral treatment, including a com- parison of the costs for equivalent services provided by programs not receiving assist- ance under this chapter; (C) estimates per-patient costs across the program and in specific categories of service providers, including— (i) urban and rural providers; (ii) country-specific providers; and (iii) other subcategories, as appropriate. (2) 2013 through 2025 studies The studies required to be submitted by Sep- tember 30, 2014, and annually thereafter through March 25, 2025, shall include, in addi- tion to the elements set forth under paragraph (1), the following elements: (A) A plan for conducting cost studies of United States assistance under section 2151b–2 of this title in partner countries, taking into account the goal for more sys- tematic collection of data, as well as the de- mands of such analysis on available human and fiscal resources. (B) A comprehensive and harmonized ex- penditure analysis by partner country, in- cluding— (i) an analysis of Global Fund and na- tional partner spending and comparable data across United States, Global Fund, and national partner spending; or Page 1977 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 7612 (ii) where providing such comparable data is not currently practicable, an expla- nation of why it is not currently prac- ticable, and when it will be practicable. (3) Publication Not later than 90 days after the completion of each study under paragraph (1), the Global AIDS Coordinator shall make the results of such study available on a publicly accessible Web site. (4) Partner country defined In this subsection, the term ‘‘partner coun- try’’ means a country with a minimum United States Government investment of HIV/AIDS assistance of at least $5,000,000 in the prior fis- cal year. (h) Message The Global AIDS Coordinator shall develop a message, to be prominently displayed by each program receiving funds under this chapter, that— (1) demonstrates that the program is a com- mitment by citizens of the United States to the global fight against HIV/AIDS, tuber- culosis, and malaria; and (2) enhances awareness by program recipi- ents that the program is an effort on behalf of the citizens of the United States. (Pub. L. 108–25, title I, § 101, May 27, 2003, 117 Stat. 718; Pub. L. 110–293, title I, § 101, July 30, 2008, 122 Stat. 2923; Pub. L. 113–56, §§ 2, 3(a), Dec. 2, 2013, 127 Stat. 648; Pub. L. 115–305, § 2, Dec. 11, 2018, 132 Stat. 4402; Pub. L. 118–47, div. F, title VII, § 7072(a), Mar. 23, 2024, 138 Stat. 852.) Editorial Notes REFERENCES IN TEXT This chapter, referred to in subsecs. (c)(2)(B)(vi), (vii), (f)(1)(A), (g)(1)(B), and (h), was in the original ‘‘this Act’’, meaning Pub. L. 108–25, May 27, 2003, 117 Stat. 711, which is classified principally to this chapter. For com- plete classification of this Act to the Code, see Short Title note set out under section 7601 of this title and Tables. AMENDMENTS 2024—Subsec. (f)(1)(A). Pub. L. 118–47, § 7072(a)(1)(A), substituted ‘‘March 25 of fiscal year 2025’’ for ‘‘2023’’. Subsec. (f)(1)(C)(iv). Pub. L. 118–47, § 7072(a)(1)(B), sub- stituted ‘‘eleven’’ for ‘‘nine’’ and ‘‘2025’’ for ‘‘2023’’. Subsec. (g)(1). Pub. L. 118–47, § 7072(a)(2)(A), sub- stituted ‘‘March 25, 2025’’ for ‘‘September 30, 2024’’ in in- troductory provisions. Subsec. (g)(2). Pub. L. 118–47, § 7072(a)(2)(B), sub- stituted ‘‘2025’’ for ‘‘2024’’ in heading and ‘‘March 25, 2025’’ for ‘‘September 30, 2024’’ in introductory provi- sions. 2018—Subsec. (f)(1)(A). Pub. L. 115–305, § 2(1)(A), sub- stituted ‘‘2023’’ for ‘‘2018’’. Subsec. (f)(1)(C)(iv). Pub. L. 115–305, § 2(1)(B), sub- stituted ‘‘nine’’ for ‘‘four’’ and ‘‘2023’’ for ‘‘2018’’. Subsec. (g)(1). Pub. L. 115–305, § 2(2)(A), substituted ‘‘2024’’ for ‘‘2019’’ in introductory provisions. Subsec. (g)(2). Pub. L. 115–305, § 2(2)(B), substituted ‘‘2024’’ for ‘‘2018’’ in heading and introductory provi- sions. 2013—Subsec. (f)(1)(A). Pub. L. 113–56, § 2(1), sub- stituted ‘‘coordinated annual plans for oversight activ- ity in each of the fiscal years 2009 through 2018’’ for ‘‘5 coordinated annual plans for oversight activity in each of the fiscal years 2009 through 2013’’. Subsec. (f)(1)(C)(ii). Pub. L. 113–56, § 2(2)(A), sub- stituted ‘‘2010 through 2013 plans’’ for ‘‘Subsequent plans’’ in heading and ‘‘the plans for fiscal years 2010 through 2013’’ for ‘‘the last four plans’’ in text. Subsec. (f)(1)(C)(iii), (iv). Pub. L. 113–56, § 2(2)(B), added cls. (iii) and (iv). Subsec. (g)(1). Pub. L. 113–56, § 3(a)(1), substituted ‘‘through September 30, 2019’’ for ‘‘through September 30, 2013’’ in introductory provisions. Subsec. (g)(2), (3). Pub. L. 113–56, § 3(a)(2), (3), added par. (2) and redesignated former par. (2) as (3). Subsec. (g)(4). Pub. L. 113–56, § 3(a)(4), added par. (4). 2008—Subsec. (a). Pub. L. 110–293, § 101(a), amended subsec. (a) generally. Prior to amendment, subsec. (a) required the President to establish a comprehensive, integrated, five-year strategy to combat global HIV/ AIDS that strengthened the capacity of the United States to be an effective leader of the international campaign against HIV/AIDS and set out standards in pars. (1) to (10) for this strategy. Subsec. (b). Pub. L. 110–293, § 101(b), amended subsec. (b) generally. Prior to amendment, subsec. (b) consisted of pars. (1) to (3) relating to presidential submission of a report to Congress setting forth the strategy de- scribed in subsec. (a). Subsec. (c). Pub. L. 110–293, § 101(c), amended subsec. (c) generally. Prior to amendment, subsec. (c) related to the study of success rates and distribution of re- sources under the strategy described in subsec. (a). Subsecs. (d) to (f). Pub. L. 110–293, § 101(d), added sub- secs. (d) to (f). Subsecs. (g), (h). Pub. L. 110–293, § 101(e), added sub- secs. (g) and (h). Statutory Notes and Related Subsidiaries CHANGE OF NAME Broadcasting Board of Governors renamed United States Agency for Global Media pursuant to section 6204(a)(21) of this title. The renaming was effectuated by notice to congressional appropriations committees dated May 24, 2018, and became effective Aug. 22, 2018. Executive Documents DELEGATION OF CERTAIN AUTHORITY UNDER THE UNITED STATES LEADERSHIP AGAINST HIV/AIDS, TUBER- CULOSIS, AND MALARIA ACT OF 2003 For delegation of functions of President under this chapter to Secretary of State, see Delegation of Func- tions note set out under section 7601 of this title. Memorandum of President of the United States, Feb. 23, 2004, 69 F.R. 9509, provided: Memorandum for the Secretary of State By the authority vested in me as President by the Constitution and the laws of the United States, includ- ing section 301 of title 3, United States Code, I hereby delegate to you the functions and authority conferred upon the President by sections 202(c), 305, and 313 of the United States Leadership Against HIV/AIDS, Tuber- culosis, and Malaria Act of 2003 (Public Law 108–25) [22 U.S.C. 7622(c), 7635, and 7653], to provide the specified reports to the Congress. In addition, I delegate to you the authority vested in the President by section 101 of Public Law 108–25 [22 U.S.C. 7611] to establish a com- prehensive, integrated, 5-year strategy to combat glob- al HIV/AIDS and to submit to the appropriate congres- sional committees a report setting forth the strategy. You are authorized and directed to publish this memorandum in the Federal Register. GEORGE W. BUSH. § 7612. HIV/AIDS response Coordinator (a) Omitted (b) Resources Not later than 90 days after May 27, 2003, the President shall specify the necessary financial